GoodRx stock falls as more than half of Wall Street’s analysts don’t recommend buying

Shares of GoodRx Holdings Inc. dropped Monday, after the prescription-drug pricing app received a less-than-enthusiastic endorsement from more than half of the Wall Street analysts who initiated research coverage.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.